MEDIPAL HOLDINGS CORPORATION
TSE Prime
¥2,886.00
+0.05%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 4,090.9 times.
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 1.42 is above 1.
- Return on equity is on the lower side at 6.7%.
- Return on capital employed is on the lower side at 6.2%.
- Net profit margin is slim at 1.1%.
- Sales growth has been slow over five years (about 4% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.62
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreWeak
3 / 4
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 4 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥5,908億
Current Price¥ 2,886.00
High / Low¥ 3,108.00 / 2,456.50
Stock P/E13.966318
Book Value¥ 3,186.01
Dividend Yield2.29%
ROCE6.23%
ROE6.70%
Debt to Equity1.42
Current Ratio1.28
P/B Ratio0.9092442
EPS¥ 206.67
PAT Margin1.11%
ICR4090.92
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity